Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|October 1, 1994
In vitro activity of DU-6859a against anaerobic bacteriaH M Wexler, E Molitoris, D Reeves, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 27, 2007
BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilisLilian Pumbwe, Abraham Chang, Rachel L Smith, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolatesHannah M Wexler, Adrian E Engel, Daniel Glass, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteriaH M Wexler, E Molitoris, D Molitoris, et al.
Infectious Disease Clinics of North America|June 1, 1993
Current perspectives on anaerobic infections: diagnostic approachesS M Finegold, H R Jousimies-Somer, H M Wexler
Compendium (Newtown, Pa.)|February 1, 1989
A dentist oriented fear reduction technique: the iatrosedative processN Friedman, J J Cecchini, M Wexler, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2006
Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolatesLilian Pumbwe, Abraham Chang, Rachel L Smith, et al.
BMC Genomics|June 6, 2014
Identification of genes required for the survival of B. fragilis using massive parallel sequencing of a saturated transposon mutant libraryYaligara Veeranagouda, Fasahath Husain, Elizabeth L Tenorio, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1991
In-vitro activity of temafloxacin against anaerobic bacteria: a comparative studyS M Finegold, E Molitoris, D Reeves, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infectionsH M Wexler, E Molitoris, D Molitoris, et al.
Pageof 16